Ketazed

Ketotifen hydrogen fumarate, the active ingredient in Ketazed, is an antihistamine/mast cell stabilizer presented as an ophthalmic solution for ocular use. It is indicated for relief of allergic conjunctivitis symptoms such as itching, redness and watery discharge in both adults and children.\n\nGNH India supplies Ketazed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketazed is used to manage ocular allergic conditions by targeting histamine‑mediated inflammation.\n\nAllergic conjunctivitis: reduces itching, redness and swelling of the conjunctiva.\nOcular itching due to allergy: alleviates persistent itch sensation on the eye surface.\nRedness caused by allergic response: diminishes visible hyperemia and discomfort.

Ketazed may cause ocular and systemic reactions, most of which are mild and reversible.\n\nCommon Side Effects:\n- Burning or stinging sensation upon instillation\n- Temporary blurred vision\n- Mild eye irritation or foreign body sensation\n- Slight headache\n- Dry eye feeling\n\nSerious or Rare Side Effects:\n- Severe allergic reaction (anaphylaxis) with swelling of eyelids or face\n- Persistent eye pain or vision loss\n- Corneal ulceration\n- Significant increase in intra‑ocular pressure\n- Contact lens intolerance

Before using Ketazed, consider the following safety measures.\n\nAvoid use in patients with known hypersensitivity to ketotifen or any formulation excipients: discontinue if reaction occurs.\nDo not apply to infected or inflamed eyes without physician guidance: may exacerbate condition.\nLimit use with contact lenses: remove lenses before instillation and wait several minutes before reinserting.\nMonitor for signs of systemic allergic reaction: seek medical attention if symptoms develop.\nStore below 25°C: keep in the original container, protect from light and moisture.

Ketazed may interact with other ocular or systemic agents.\n\nMajor Interactions (Avoid):\n- Preservative‑containing contact lens solutions: can cause incompatibility and increased irritation.\n- Topical ophthalmic anesthetics: may potentiate corneal toxicity when used together.\n\nModerate Interactions (Monitor Closely):\n- Systemic antihistamines: additive sedation or dry eye symptoms.\n- Other mast cell stabilizers: may increase risk of ocular irritation.\n- Non‑steroidal anti‑inflammatory eye drops: monitor for enhanced inflammation control.